Stevens has served as Chief Executive Officer and a director of Structure Therapeutics (formerly ShouTi), a biotechnology company, since May 2019. He was Provost Professor of Biological Sciences and Chemistry and Founder and Director of The Bridge Institute at the University of Southern California from July 2014 to August 2021, and Professor of Molecular Biology and Chemistry at The Scripps Research Institute from 1999 to July 2014. A pioneer in human cellular behavior research, he has been involved in creating breakthrough drugs targeting influenza, childhood diseases, neuromuscular disorders and diabetes, and serves on Danaher's Audit and Science & Technology Committees.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.